UK Britain
Biotech

A year after Big Pharma’s pull-back from the UK, what’s changed?

A year on from Big Pharma's protest at U.K. drug pricing policy, Fierce reached out to the companies involved to see if they've softened their stance.
James Waldron Sep 4, 2026 10:00am
georgeliforfiercebiotechjpg

China in Global Clinical Development: Why Early Inclusion Matters

Brought to you by Syneos Health
Ionis headquarters
Favicon Fierce Pharma

Ionis scores ‘breakthrough’ rare disease approval

Sep 4, 2026 11:18am
Italy China Flags

Menarini inks $771M deal to take Gan & Lee GLP-1 to Europe

Sep 4, 2026 11:00am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Invivyd's chair adds CEO role ahead of readout—Chutes & Ladders

Sep 4, 2026 8:30am
mushrooms psychedelic drugs psychedelics

Psilocybin proves promising in neuropathic pain mouse study

Sep 3, 2026 2:00pm
More News

Pfizer offloads scrapped Seagen ADC to Medicus Pharma

Sep 3, 2026 11:31am

Why Roche is 'really excited' about UCN2's obesity potential

Sep 3, 2026 10:47am

Fierce Biotech Fundraising Tracker '26: Superluminal & more

Sep 3, 2026 10:00am

AbbVie bispecific shows promise in ph. 3 multiple myeloma trial

Sep 3, 2026 9:20am